---
$id: https://graph.org.ai/products/commodity/51142308
$type: Product
source: UNSPSC
code: "51142308"
title: "Nalorphine"
class: "51142300"
classTitle: "Narcotic antagonists"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nalorphine

**UNSPSC Code**: 51142308
**Class**: [Narcotic antagonists](Narcotic antagonists.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a narcotic antagonist with the molecular formula C19H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U59WB2WRY2, chemically known as 7,8-didehydro-4,5-epoxy-17-(2-propenyl)morphinan-3,6-diol but generally known as nalorphine, which bears US NIH Compound Identifier 5284595. European Medicines Agency schedules Nalorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09141MIG. World Health Organization schedules nalorphine in its Anatomical Therapeutic Chemical (ATC) Classification. NALORPHINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nalorphine under HS 29391900 and SITC 54141. As of Q4 2014, NALORPHINE remains the US FDA Preferred Term for this commodity. SMILES: O1C2C34C(C(N(CC3)CC=C)CC3C4C1C(O)CC3)C=CC2O.

